Thyroiditis, Autoimmune: Clinical Trials

4 trials for Thyroiditis, Autoimmune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed. 4 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 3, Completed 1
Phase 23Recruiting 2, Completed 1

Follow Thyroiditis, Autoimmune: new trials by email Literature Review of Thyroiditis, Autoimmune trials Research Report on Thyroiditis, Autoimmune

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
linsitinib, Placebo - Thyroid Eye Disease, TED, Graves Orbitopathy
Phase 3RecruitingSling Therapeutics, Inc.1302026-08-042026-10-20
Colchicine for Autoimmune and Subacute Thyroiditis
colchicine, Prednisolone, NSAID - Hashimoto Thyroiditis, Subacute Thyroiditis
Phase 2 / Phase 3RecruitingMansoura University3002026-06-152026-07-29
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
linsitinib - Thyroid Eye Disease, Graves Orbitopathy
Phase 2 / Phase 3RecruitingSling Therapeutics, Inc.752023-10-112025-02-25
A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
Linsitinib, Placebo - Thyroid Eye Disease, Graves Orbitopathy
Phase 2 / Phase 3CompletedSling Therapeutics, Inc.902022-07-012026-09-23

Narrower conditions

Hashimoto Disease (4)  ·  Graves Ophthalmopathy (3)  ·  Endocrine System Diseases (2)  ·  Exophthalmos (2)  ·  Eye Diseases (2)  ·  Orbital Diseases (2)  ·  Thyroid Diseases (2)  ·  Graves Disease (1)  ·  Inflammation (1)  ·  Thyroiditis (1)  ·  Thyroiditis, Subacute (1)

Broader conditions

Autoimmune Diseases (4)  ·  Immune System Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Eye Diseases, Hereditary (3)  ·  Genetic Diseases, Inborn (3)  ·  Goiter (3)  ·  Hyperthyroidism (3)  ·  Thyroiditis (3)  ·  Endocrine System Diseases (2)  ·  Graves Disease (2)  ·  Thyroid Diseases (2)  ·  Exophthalmos (1)  ·  Eye Diseases (1)  ·  Orbital Diseases (1)

Interventions

3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol (3)  ·  Anti-Inflammatory Agents, Non-Steroidal (1)  ·  Colchicine (1)  ·  Prednisolone (1)

Sponsors

Sling Therapeutics, Inc. (3)  ·  Mansoura University (1)

Countries

United States (3)  ·  Canada (1)  ·  Egypt (1)  ·  Italy (1)  ·  Saudi Arabia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Amr A. El Sehrawy, MD, PhD, FRCPE (1)